Effects of dyslipidemia and smoking on macrovascular disease in type 2 diabetes

被引：0
|
作者：
Herskovits, AT
Chajek-Shaul, T
机构：
来源：
DIABETES | 1998年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1406
引用
收藏
页码：A364 / A364
页数：1
相关论文
共 50 条
  • [1] Risk factors for macrovascular disease in type 2 diabetes
    Higa, M
    Kaneko, Y
    [J]. DIABETES, 2003, 52 : A470 - A470
  • [2] Progressive macrovascular disease in a population with Type 2 diabetes
    Pedula, KL
    Hillier, TA
    Brown, JB
    Lydick, E
    [J]. DIABETOLOGIA, 1999, 42 : A48 - A48
  • [3] Type 2 diabetes and macrovascular disease: Epidemiology and etiology
    Clark, CM
    Perry, RC
    [J]. AMERICAN HEART JOURNAL, 1999, 138 (05) : S330 - S333
  • [4] Myeloperoxidase is associated with macrovascular disease in type 2 diabetes
    Brennan, ML
    Saremi, A
    Hayden, CT
    Sacks, J
    Schwenke, D
    Hayden, CT
    Hazen, SL
    Reaven, PD
    Hayden, CT
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) : E60 - E61
  • [5] Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease?
    Oranje, WA
    Rondas-Colbers, GJWM
    Swennen, GNM
    Wolffenbuttel, BHR
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1998, 53 (02): : 61 - 68
  • [6] Preventing Macrovascular Disease in Patients with Type 2 Diabetes Mellitus
    Odd E. Johansen
    Kåre I. Birkeland
    [J]. American Journal of Cardiovascular Drugs, 2003, 3 (4) : 283 - 297
  • [7] Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease
    Ay, Leyla
    Hoellerl, Florian
    Ay, Cihan
    Brix, Johanna-Maria
    Koder, Silvia
    Schernthaner, Gerit-Holger
    Pabinger, Ingrid
    Schernthaner, Guntram
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (05) : 470 - 477
  • [8] Predictors of macrovascular disease in patients with type 2 diabetes mellitus
    Abu-Lebdeh, HS
    Hodge, DO
    Nguyen, TT
    [J]. MAYO CLINIC PROCEEDINGS, 2001, 76 (07) : 707 - 712
  • [9] Metformin: Effects on Micro and Macrovascular Complications in Type 2 Diabetes
    Clifford J. Bailey
    [J]. Cardiovascular Drugs and Therapy, 2008, 22 : 215 - 224
  • [10] Macrovascular Effects and Safety Issues of Therapies for Type 2 Diabetes
    Plutzky, Jorge
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (03): : 25B - 32B
12345